Shanghai Pharmaceuticals Holding Co., Ltd (SHA: 601607)

Shanghai Pharmaceuticals Holding Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 18, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	72,452	56,107	60,072	49,277	47,493	47,781
Market Cap Growth	14.18%	-6.60%	21.91%	3.76%	-0.60%	4.92%
Enterprise Value	98,611	80,065	81,075	76,701	71,525	70,913
Last Close Price	22.07	16.32	16.88	18.37	17.33	16.20
PE Ratio	20.43	16.03	10.49	10.26	10.97	11.28
Forward PE	16.24	8.08	14.04	10.35	11.36	11.29
PS Ratio	0.30	0.22	0.26	0.23	0.25	0.26
PB Ratio	1.15	0.70	0.77	0.83	0.87	0.97
P/TBV Ratio	1.29	1.10	1.21	1.54	1.65	1.77
P/FCF Ratio	25.62	24.82	29.18	52.28	12.38	14.62
P/OCF Ratio	12.15	10.72	12.66	9.74	6.94	7.93
PEG Ratio	1.10	0.67	0.61	0.76	0.84	0.84
EV/Sales Ratio	0.36	0.31	0.35	0.36	0.37	0.38
EV/EBITDA Ratio	9.57	8.07	8.37	8.55	8.15	8.39
EV/EBIT Ratio	11.72	9.33	9.93	10.27	9.82	9.95
EV/FCF Ratio	30.91	35.41	39.39	81.38	18.65	21.69
Debt / Equity Ratio	0.68	0.65	0.57	0.69	0.67	0.70
Debt / EBITDA Ratio	5.46	4.89	4.29	4.24	3.90	3.84
Debt / FCF Ratio	17.63	22.96	21.67	43.25	9.58	10.59
Asset Turnover	1.25	1.27	1.28	1.38	1.34	1.41
Inventory Turnover	6.67	6.45	6.55	7.32	6.77	6.42
Quick Ratio	1.02	0.98	0.99	0.93	0.90	0.93
Current Ratio	1.34	1.33	1.35	1.27	1.22	1.31
Return on Equity (ROE)	6.41%	6.53%	10.20%	11.03%	10.77%	10.08%
Return on Assets (ROA)	2.41%	2.62%	2.82%	2.99%	3.18%	3.37%
Return on Capital (ROIC)	3.86%	4.21%	4.59%	4.88%	5.19%	5.49%
Earnings Yield	4.89%	6.72%	9.35%	10.34%	9.47%	8.54%
FCF Yield	3.90%	4.03%	3.43%	1.91%	8.07%	6.84%
Dividend Yield	1.87%	2.51%	3.61%	2.29%	2.77%	2.72%
Payout Ratio	85.84%	105.66%	55.08%	52.54%	53.79%	63.32%
Buyback Yield / Dilution	0.83%	-6.28%	-22.54%	-	-	-0.45%
Total Shareholder Return	2.70%	-3.76%	-18.93%	2.29%	2.77%	2.26%

Source: S&P Capital IQ. Standard template. Financial Sources.